ARENA PHARMACEUTICALS INC's ticker is ARNA and the CUSIP is 040047607. A total of 229 filers reported holding ARENA PHARMACEUTICALS INC in Q4 2019. The put-call ratio across all filers is 2.96 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $587,000 | -24.2% | 8,618 | -22.8% | 0.02% | -25.9% |
| Q1 2021 | $774,000 | -78.4% | 11,168 | -76.1% | 0.03% | -77.9% |
| Q4 2020 | $3,591,000 | -23.9% | 46,768 | -25.9% | 0.12% | -21.3% |
| Q3 2020 | $4,720,000 | +15.0% | 63,131 | -3.1% | 0.16% | +38.4% |
| Q2 2020 | $4,104,000 | +40.7% | 65,179 | -6.1% | 0.11% | +28.7% |
| Q1 2020 | $2,916,000 | -5.2% | 69,447 | +2.6% | 0.09% | +22.5% |
| Q4 2019 | $3,075,000 | -27.5% | 67,690 | -27.0% | 0.07% | -25.3% |
| Q3 2019 | $4,243,000 | -22.8% | 92,739 | -1.1% | 0.10% | -23.4% |
| Q2 2019 | $5,497,000 | +98.4% | 93,739 | +51.6% | 0.12% | +121.4% |
| Q1 2019 | $2,771,000 | -26.7% | 61,839 | -36.2% | 0.06% | -30.9% |
| Q4 2018 | $3,778,000 | -2.5% | 96,981 | +15.2% | 0.08% | +17.4% |
| Q3 2018 | $3,874,000 | -1.5% | 84,195 | -6.7% | 0.07% | +1.5% |
| Q2 2018 | $3,934,000 | -16.3% | 90,249 | -24.2% | 0.07% | -16.0% |
| Q1 2018 | $4,702,000 | +71.1% | 119,030 | +47.2% | 0.08% | +72.3% |
| Q4 2017 | $2,748,000 | +27.5% | 80,868 | -4.4% | 0.05% | -6.0% |
| Q3 2017 | $2,156,000 | – | 84,582 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Prosight Management, LP | 252,500 | $11,320,000 | 4.95% |
| Rubric Capital Management LP | 857,103 | $38,424,000 | 3.59% |
| PFM Health Sciences, LP | 3,255,230 | $145,932,000 | 3.22% |
| Partner Investment Management, L.P. | 40,605 | $1,820,000 | 2.10% |
| DAFNA Capital Management LLC | 93,942 | $4,211,000 | 1.82% |
| Atika Capital Management LLC | 195,000 | $8,742,000 | 1.78% |
| Perceptive Advisors | 1,400,171 | $62,770,000 | 1.77% |
| EMORY UNIVERSITY | 47,779 | $2,142,000 | 1.51% |
| Rhenman & Partners Asset Management AB | 234,558 | $10,515,000 | 1.23% |
| Eversept Partners, LP | 75,721 | $3,394,572 | 0.99% |